LINC 2023: Late-breaking Science Video Collection

Published: 20 June 2023

Views:
794
Likes:
7

Views:
794
Likes:
7
Share:

Now Playing
Part 1 | Session 6 of 9
POPCORN Registry: DCB Treatment for Peripheral Artery Disease
Yoshimitsu Soga

Up Next
3m 49s

Part 1 | Session 7 MOTIV Bioresorbable Scaffold in BTK Lesions
Michel Bosiers
6m 6s

Part 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
Marc Sirvent
8m 56s

Part 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
Sahil Parikh

5m 2s

Part 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study Scott O Trerotola

5m 18s

Part 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups Marianne Brodmann

4m 51s

Part 1 | Session 3 RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety Marianne Brodmann

4m 48s

Part 1 | Session 4 IN.PACT AV ACCESS: Outcomes to Date Matteo Tozzi

8m 14s

Part 1 | Session 5 TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes Koen Deloose

Average (ratings)

No ratings

Your rating

Overview

Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Expert Interviews

Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.

9 sessions
AVPAS: Lutonix AV Post-Approval Study	Watch now
The ELEGANCE Registry: Ranger DCB In Under-Represented Groups	Watch now
RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety	Watch now
IN.PACT AV ACCESS: Outcomes to Date	Watch now
TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes	Watch now
POPCORN Registry: DCB Treatment for Peripheral Artery Disease	Watch now
MOTIV Bioresorbable Scaffold in BTK Lesions	Watch now
Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK	Watch now
LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions	Watch now

About the episode

LINC 23 - We are joined by Dr Yoshimitsu Soga (Kokura Memorial Hospital, JP) to discuss the POPCORN Registry, an ongoing prospective multicenter observational study of drug-coated balloons (DCBs) in patients with peripheral artery disease (PAD). This is the largest Japanese DCB registry, with 81 institutions enrolled in the trial.

The primary objective of this registry is to compare the performance of two prominent DCBs, Lutonix and IN.PACT Admiral, in a cohort of 2507 patients over a span of 5 years. The 2-year results suggest that primary patency after drug-coated balloon stenting for femoropopliteal lesions in a real-world setting was favourable. The study also suggested that an accumulation of primary restenosis risk factors was associated with lower patency, and a lower freedom from target lesion revascularization rate.

Interview Questions:

What was the reasoning behind the POPCORN Registry?
What are the differences between the Lutonix and IN.PACT Admiral DCBs?
What was the patient population and study design?
What are the key findings revealed at LINC 23?
How should these findings impact both clinical practice and future research?
What are the next steps?

Recorded remotely from Belgium, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent

Faculty Biographies

Yoshimitsu Soga

View full profile

Comments

You must be to comment. If you are not registered, you can register here.